X0306 4 2016-01-08 0 0001029730 LADENBURG THALMANN FINANCIAL SERVICES INC LTS 0000898860 FROST PHILLIP MD ET AL 4400 BISCAYNE BOULEVARD MIAMI FL 33137 1 0 1 0 0001380896 Frost Gamma Investments Trust 4400 BISCAYNE BOULEVARD MIAMI FL 33137 0 0 1 0 0001464124 Frost Nevada Investments Trust 4400 BISCAYNE BOULEVARD MIAMI FL 33137 0 0 1 0 Common Stock 2016-01-08 4 P 0 10000 2.4396 A 12671199 I Frost Gamma Investments Trust Common Stock 20000 D Common Stock 43013431 I Frost Nevada Investments Trust 8.00% Series A Cumulative Redeemable Preferred Stock 910000 I Frost Nevada Investments Trust The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee and Frost Gamma, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of two limited partners of Frost Gamma, L.P. The general partner of Frost Gamma, L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. The Reporting Person is also the sole shareholder of Frost-Nevada Corporation. These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of five limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The 8.00% Series A Cumulative Redeemable Preferred Stock is convertible into common stock at a non-fixed conversion rate in connection with a change of control as described in the issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on May 24, 2013. /s/ Phillip Frost, M.D. 2016-01-11 /s/ Phillip Frost, M.D., Trustee 2016-01-11 /s/ Phillip Frost, M.D., Trustee 2016-01-11